1-3 of 3
Dixil Francis, MPH
Close
Sort by
Journal Articles

The Multiple Myeloma Research Consortium (MMRC) Model: Reduced Time to Trial Activation and Improved Accrual Metrics.

Sandra Wear, RN, Paul G. Richardson, MD, Carolyn Revta, MPH, Ravi Vij, MBBS, MD, Mark Fiala, BS, CCRP, Sagar Lonial, MD, Dixil Francis, MPH, CCRC, David Samuel diCapua Siegel, MD, PhD, Alex Schramm, BA, Andrzej J. Jakubowiak, MD, PhD, Colleen K. Harvey, Donna E. Reece, MD, Engin Gul, HonBSc, Sundar Jagannath, MD, Lisa La, MS, Craig C. Hofmeister, MD, Buffy Jansak, BSN, OCN, Keith Stewart, MBA, MB, CHB, Rachel Hagerty, Jeffrey L. Wolf, MD, Beth Davis, Amrita Krishnan, MD, Lupe Duarte, CCRC, Todd M. Zimmerman, MD, Angela Cisneros, Shaji Kumar, MD, Ann Birgin, CRA, Robert Ott, MBA, Leah Tasca, Susan L. Kelley, MD, Kenneth C. Anderson, MD, Kathy Giusti, MBA
Journal: Blood
Blood (2010) 116 (21): 3803.
https://doi.org/10.1182/blood.V116.21.3803.3803
Published: 2010
Journal Articles

Preliminary Results of a Phase I Study of the Pan-PI3 Kinase Inhibitor SF1126 in Patients with Relapsed and Refractory Myeloma.

Sagar Lonial, MD, R. Donald Harvey, Pharm, D., Dixil Francis, MPH, Engin Gul, Sundar Jagannath, MD, Sherif Farag, MBBS, PhD, Daniel Hoth, MD, Robert Frumento, M.S., MPH, Joseph R. Garlich, PhD, Suzanne Trudel, MD
Journal: Blood
Blood (2009) 114 (22): 3879.
https://doi.org/10.1182/blood.V114.22.3879.3879
Published: 2009
Journal Articles

A Phase I Clinical Trial Testing the Combination of Bortezomib and Tipifarnib in Relapsed/Refractory Multiple Myeloma.

Sagar Lonial, MD, Dixil Francis, MPH, Chatchada Karanes, Suzanne Trudel, MD, Akari M. Dollard, Fermin Aceo, Engin Gul, Sumeet Kakar, Amrita Y. Krishnan, MD, FACP, Donna E. Reece, MD, R. Donald Harvey, PharmD, Jonathan L. Kaufman, MD
Journal: Blood
Blood (2009) 114 (22): 3851.
https://doi.org/10.1182/blood.V114.22.3851.3851
Published: 2009